PCR-based pre-emptive therapy of cytomegalovirus infections after allogeneic stem cell transplantation with sequential intravenous ganciclovir foscarnet and oral ganciclovir.

被引：0
|
作者：
Chakrabarti, S [1 ]
Collingham, K [1 ]
Pillay, D [1 ]
Milligan, DW [1 ]
机构：
[1] Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1999年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
119
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [1] An open-label randomised study of oral valganciclovir versus intravenous ganciclovir for pre-emptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation
    Volin, L.
    Barkholt, L.
    Nihtinen, A.
    Aschan, J.
    Uotinen, H.
    Haegglund, H.
    Juvonen, E.
    Ringden, O.
    Ruutu, T.
    Ljungman, P.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S47 - S47
  • [2] Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients
    van der Heiden, PLJ
    Kalpoe, JS
    Barge, RM
    Willemze, R
    Kroes, ACM
    Schippers, EF
    BONE MARROW TRANSPLANTATION, 2006, 37 (07) : 693 - 698
  • [3] Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients
    P L J van der Heiden
    J S Kalpoe
    R M Barge
    R Willemze
    A C M Kroes
    E F Schippers
    Bone Marrow Transplantation, 2006, 37 : 693 - 698
  • [4] The use of intravenous and oral ganciclovir combination in pre-emptive treatment of CMV-PCR positive patients after allogeneic hematopoietic stem cell transplantation.
    Halaburda, K
    Gryckiewicz, R
    Pawelczyk, T
    Hellmann, A
    BONE MARROW TRANSPLANTATION, 1998, 21 : S142 - S142
  • [5] Combined Foscarnet-Ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation
    Bacigalupo, A
    Bregante, S
    Tedone, E
    Isaza, A
    VanLint, MT
    Trespi, G
    Occhini, D
    Gualandi, F
    Lamparelli, T
    Marmont, AM
    TRANSPLANTATION, 1996, 62 (03) : 376 - 380
  • [6] Pre-emptive oral vs. IV ganciclovir therapy against cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation (Hsct) in patients with solid tumor
    Barkholt, L
    Lewensohn-Fuchs, I
    Hentschke, P
    Stahle, L
    Helldén, A
    Ringdén, O
    BONE MARROW TRANSPLANTATION, 2002, 29 : S192 - S192
  • [7] Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after Allogeneic hemopoietic stem cell transplantation (Hsct)
    Bacigalupo, A
    Bregante, S
    Tedone, E
    Isaza, A
    VanLint, MT
    Moro, F
    Trespi, G
    Occhini, D
    Gualandi, F
    Lamparelli, T
    Marmont, AM
    BONE MARROW TRANSPLANTATION, 1996, 18 : 110 - 114
  • [8] Prospective study of oral valganciclovir for pre-emptive therapy of cytomegalovirus after allogeneic stem cell transplantation
    de la Camara, R.
    Vazquez, L.
    Lopez, J.
    Solano, C.
    Serrano, D.
    Garcia Noblejas, A.
    Ribera Santasusana, J. M.
    Ferra, C.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S246 - S247
  • [9] Oral valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic stem cell transplantation recipients
    Michael, M.
    Kourti, G.
    Bouzani, M.
    Grispou, O.
    Anagnostopoulou, M.
    Baltathakis, I.
    Apostolidis, I.
    Karakasis, D.
    Harhalakis, N.
    Paniara, O.
    Nikiforakis, E.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S285 - S286
  • [10] Oral valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic stem cell transplantation recipients
    Pastore, D.
    Carluccio, P.
    Gaudio, F.
    Perrone, T.
    Delia, M.
    Albano, F.
    Manduzio, P.
    Fesce, V.
    Mongelli, P.
    Liso, V.
    Specchia, G.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S266 - S267
12345